Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Beth A. Erickson MD

Beth A. Erickson MD

Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center

View Curriculum Vitae

Publications

  • American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. (Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L) Brachytherapy 2017 Sep 06 PMID: 28888417 09/11/2017
  • Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017 Jun 29 PMID: 28886941 09/10/2017
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Aug 28 PMID: 28849366 08/30/2017
  • Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. (Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA) PLoS One 2017;12(6):e0178961 PMID: 28575105 PMCID: PMC5456365 06/03/2017
  • The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. (Grover S, Longo J, Einck J, Puri P, Brown D, Chino J, Mahantshetty U, Yashar C, Erickson B) Semin Radiat Oncol 2017 Apr;27(2):136-142 PMID: 28325239 03/23/2017
  • Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies. (Dhakal B, Fenske TS, Ramalingam S, Shuff J, Epperla N, Hosking P, Rein L, Banerjee A, Hari P, D'Souza A, Shah N, Siker M, Griepentrog GJ, Harris GJ, Wells TS, Erickson BA, Hamadani M) Clin Lymphoma Myeloma Leuk 2017 May;17(5):305-311.e2 PMID: 28284742 03/13/2017
  • Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 Mar;13(3):171-172 PMID: 28282275 03/11/2017
  • American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. (Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B) Brachytherapy 2017 Jan - Feb;16(1):22-43 PMID: 28109631 PMCID: PMC5497694 01/23/2017
  • The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. (Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJ) Brachytherapy 2017 Jan - Feb;16(1):68-74 PMID: 28109633 01/23/2017
  • The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. (Erickson BA, Bittner NH, Chadha M, Mourtada F, Demanes DJ) Brachytherapy 2017 Jan - Feb;16(1):75-84 PMID: 28109634 01/23/2017
  • Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CA, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017 Mar - Apr;7(2):126-136 PMID: 28089481 01/17/2017
  • SU-F-J-173: Online Replanning for Dose Painting Based On Changing ADC Map of Pancreas Cancer. (Ates O, Ahunbay E, Erickson B, Li X) Med Phys 2016 Jun;43(6):3447-3448 PMID: 28046785 01/04/2017
  • SU-F-R-55: Early Detection of Treatment Induced Bone Marrow Injury During Chemoradiation Therapy Using Quantitative CT. (Chen X, Song Y, Erickson B, Li X) Med Phys 2016 Jun;43(6):3385-3386 PMID: 28047528 01/04/2017
  • SU-F-R-50: Radiation-Induced Changes in CT Number Histogram During Chemoradiation Therapy for Pancreatic Cancer. (Chen X, Schott D, Song Y, Li D, Hall W, Erickson B, Li X) Med Phys 2016 Jun;43(6):3384 PMID: 28048091 01/04/2017
  • American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. (Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D) Brachytherapy 2017 Jan - Feb;16(1):85-94 PMID: 27919654 12/07/2016
  • Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. (Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S) J Gastrointest Surg 2017 Mar;21(3):496-505 PMID: 27896658 11/30/2016
  • Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. (Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB) J Oncol Pract 2016 Oct;12(10):915-923 PMID: 27858562 11/20/2016
  • Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? (Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S) J Surg Oncol 2016 Oct;114(5):581-586 PMID: 27760280 10/22/2016
  • The Impact of Dose on Overall Survival in Unresectable Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. (Hammad AY, Schmid RK, Erickson BA, Gamblin TC, Robbins JR) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E152 PMID: 27673914 09/28/2016
  • Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer. (Schott D, Hall WA, Gilat Schmidt T, Dalah E, Oshima K, Paulson ES, Knechtges PM, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S70 PMID: 27675998 09/28/2016
  • Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer. (Viswanathan AN, Winter K, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis U, Horowitz N, Mannel R, Souhami L, Erickson BA, Small W Jr, Gaffney DK) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S49-S50 PMID: 27675942 09/28/2016
  • Correlation of SMAD4 Expression in Pretreatment Cytologic Specimens and Postneoadjuvant Treatment Surgical Specimens in Patients With Pancreatic Cancer. (Kharofa JR, Barnes C, Mackinnon A, George B, Ritch P, Christians K, Evans D, Erickson BA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S141 PMID: 27675627 09/28/2016
  • Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma. (Yashar CM, Petersen IA, Bosch WR, Albuquerque KV, Beriwal S, Chino JP, Erickson BA, Feddock J, Gaffney DK, Iyer R, Klopp AH, Kunos C, Mayadev JS, Portelance L, Viswanathan AN, Wolfson AH, Jhingran A, Mell LK) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S13-S14 PMID: 27675597 09/28/2016
  • Complex Abdominal Organ Motion Assessed From Magnetic Resonance Imaging. (Omari EA, Song Y, Christian J, Paulson ES, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E696-E697 PMID: 27675387 09/28/2016
  • Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer. (Song Y, Chen X, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E303-E304 PMID: 27674323 09/28/2016
  • Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA). (Hall WA, Lans D, Arce-Lara C, Kelley MJ, Santana-Davila R, Marcus DM, Tsai S, Ridolfi T, Erickson BA, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E186 PMID: 27674006 09/28/2016
  • Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate With Pathologic Molecular Markers: An Exploratory Analysis. (Hall WA, Paulson ES, Vistocky A, Tsai S, Koay EJ, Knechtges PM, Evans D, Christians K, Ritch P, George B, Oshima K, Li A, Erickson BA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E178-E179 PMID: 27673981 09/28/2016
  • A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy. (Moningi S, Amer A, Colbert LE, Lee Y, Hall WA, Erickson BA, Varadhachary GR, Das P, Taniguchi CM, Fleming JB, Katz M, Crane CH, Koay EJ) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E171-E172 PMID: 27673966 09/28/2016
  • Evolution of the Management of Resectable Pancreatic Cancer. (Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB) J Oncol Pract 2016 Sep;12(9):772-8 PMID: 27621326 09/14/2016
  • Preliminary results on the feasibility of using ultrasound to monitor intrafractional motion during radiation therapy for pancreatic cancer. (Omari EA, Erickson B, Ehlers C, Quiroz F, Noid G, Cooper DT, Lachaine M, Li XA) Med Phys 2016 Sep;43(9):5252 PMID: 27587056 09/03/2016
  • Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer. (Asare EA, Evans DB, Erickson BA, Aburajab M, Tolat P, Tsai S) J Surg Oncol 2016 Sep;114(3):291-5 PMID: 27264017 06/07/2016
  • Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. (Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W) Int J Radiat Oncol Biol Phys 2016 Jul 15;95(4):1191-200 PMID: 27130794 PMCID: PMC5189987 05/01/2016
  • MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers. (Prior P, Chen X, Botros M, Paulson ES, Lawton C, Erickson B, Li XA) Phys Med Biol 2016 05 21;61(10):3819-42 PMID: 27089554 04/19/2016
  • Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society. (Grover S, Harkenrider MM, Cho LP, Erickson B, Small C, Small W Jr, Viswanathan AN) Int J Radiat Oncol Biol Phys 2016 Mar 01;94(3):598-604 PMID: 26867888 02/13/2016
  • Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society. (Harkenrider MM, Grover S, Erickson BA, Viswanathan AN, Small C, Kliethermes S, Small W Jr) Brachytherapy 2016 Jan-Feb;15(1):23-9 PMID: 26620818 12/02/2015
  • Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 PMID: 26602840 11/26/2015
  • The American Board of Radiology Focused Practice Recognition in Brachytherapy (FPRB) Program: Opportunities lost, lessons learned, and future implications. (Wallner PE, Kupelian P, Erickson B, Alektiar KM, Laszakovits D, Henson TM, Wang PC, Steinberg ML) Pract Radiat Oncol 2015 Nov-Dec;5(6):427-32 PMID: 26547827 11/10/2015
  • Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. (Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A) Pract Radiat Oncol 2015 Nov-Dec;5(6):e557-65 PMID: 26432679 PMCID: PMC4884648 10/04/2015
  • Neoadjuvant therapy for localized pancreatic cancer: guiding principles. (Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB, Tsai S) J Gastrointest Oncol 2015 Aug;6(4):418-29 PMID: 26261728 PMCID: PMC4502155 08/12/2015
  • Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 PMID: 26255895 PMCID: PMC4571763 08/11/2015
  • Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. (Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S) Surgery 2015 Dec;158(6):1545-55 PMID: 26243342 08/06/2015
  • Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. (Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A) Brachytherapy 2015 Sep-Oct;14(5):587-99 PMID: 26186975 07/19/2015
  • SU-E-J-271: Correlation of CT Number Change with Radiation Treatment Response for Pancreatic Cancer. (Dalah E, Tai A, Oshima K, Hall W, Knechtges P, Erickson B, Li X) Med Phys 2015 Jun;42(6):3329 PMID: 26127663 07/02/2015
  • SU-E-J-65: Motion Difference Between the Pancreas and Nearby Veins for Pancreas Motion Monitoring Using Ultrasound During Radiation Therapy. (Omari E, Zhang J, Erickson B, Li X) Med Phys 2015 Jun;42(6):3278 PMID: 26127456 07/02/2015
  • SU-D-210-06: Feasibility for Monitoring the Head of the Pancreas Motion Through a Surrogate Using Ultrasound During Radiation Therapy Delivery. (Omari E, Noid G, Ehlers C, Erickson B, Quiroz F, Cooper D, Lachaine M, Li X) Med Phys 2015 Jun;42(6):3223 PMID: 26127230 07/02/2015
  • TU-G-BRA-06: PET-Based Treatment Response Assessement for Neoadjuvent Chemoradiation for Pancreatic Adenocarcinoma. (Dalah E, Tai A, Oshima K, Hall W, Erickson B, Li X) Med Phys 2015 Jun;42(6):3631 PMID: 26129058 07/02/2015
  • WE-G-BRD-07: Automated MR Image Standardization and Auto-Contouring Strategy for MRI-Based Adaptive Brachytherapy for Cervix Cancer. (Saleh HA, Erickson B, Paulson E) Med Phys 2015 Jun;42(6):3689 PMID: 26129363 07/02/2015
  • NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. (Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK) Cancer 2015 Jul 01;121(13):2156-63 PMID: 25847373 PMCID: PMC4685031 04/08/2015
  • Evolving traditions on the technology journey. (Erickson B) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):14-6 PMID: 25835618 04/04/2015
  • Promises and Pitfalls: Development of the National Brachytherapy Registry. (Wallner PE, Kupelian P, Erickson B, Alektiar K) J Am Coll Radiol 2015 Jul;12(7):670-1 PMID: 25769237 03/15/2015
  • Seeing is saving: the benefit of 3D imaging in gynecologic brachytherapy. (Viswanathan AN, Erickson BA) Gynecol Oncol 2015 Jul;138(1):207-15 PMID: 25748646 03/10/2015
  • Brachytherapy: where has it gone? (Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE) J Clin Oncol 2015 Mar 20;33(9):980-2 PMID: 25667278 PMCID: PMC5320953 02/11/2015
  • Neoadjuvant therapy for localized pancreatic cancer: support is growing? (Evans DB, Ritch PS, Erickson BA) Ann Surg 2015 Jan;261(1):18-20 PMID: 25599323 01/20/2015
  • Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning. (Paulson ES, Erickson B, Schultz C, Allen Li X) Med Phys 2015 Jan;42(1):28-39 PMID: 25563245 01/08/2015
  • Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23 PMID: 25446610 PMCID: PMC4385459 12/03/2014
  • Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. (Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B) Radiother Oncol 2014 Oct;113(1):41-6 PMID: 25443499 PMCID: PMC4530020 12/03/2014
  • Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. (Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W) Int J Radiat Oncol Biol Phys 2014 Oct 01;90(2):320-8 PMID: 25304792 PMCID: PMC4194192 10/12/2014
  • Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. (Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S) J Gastrointest Surg 2014 Nov;18(11):2016-25 PMID: 25227638 09/18/2014
  • Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8 PMID: 25159502 08/28/2014
  • ACR appropriateness Criteria® advanced stage endometrial cancer. (Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK, Expert Panel on Radiation Oncology-Gynecology:) Am J Clin Oncol 2014 Aug;37(4):391-6 PMID: 24977691 07/01/2014
  • Consolidating duodenal and small bowel toxicity data via isoeffective dose calculations based on compiled clinical data. (Prior P, Tai A, Erickson B, Li XA) Pract Radiat Oncol 2014 Mar-Apr;4(2):e125-31 PMID: 24890358 06/04/2014
  • A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. (Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ) Pract Radiat Oncol 2014 Mar-Apr;4(2):65-70 PMID: 24890345 06/04/2014
  • 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014 Jul-Aug;13(4):319-25 PMID: 24837024 05/20/2014
  • Arterial resection at the time of pancreatectomy for cancer. (Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB) Surgery 2014 May;155(5):919-26 PMID: 24787115 05/03/2014
  • Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. (Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK) Eur J Cancer 2014 Jul;50(10):1747-57 PMID: 24767470 04/29/2014
  • The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. (Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN, American Society for Radiation Oncology) Pract Radiat Oncol 2014 May-Jun;4(3):137-44 PMID: 24766678 04/29/2014
  • Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. (Dalah E, Moraru I, Paulson E, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2014 Jul 01;89(3):633-40 PMID: 24755533 04/24/2014
  • Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models. (Moraru IC, Tai A, Erickson B, Li XA) Pract Radiat Oncol 2014 Jan-Feb;4(1):13-9 PMID: 24621418 03/14/2014
  • Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. (Yang C, Liu F, Ahunbay E, Chang YW, Lawton C, Schultz C, Wang D, Firat S, Erickson B, Li XA) Pract Radiat Oncol 2014 Jan-Feb;4(1):e75-83 PMID: 24621436 03/14/2014
  • Acr appropriateness Criteria management of vaginal cancer. (Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK) Oncology (Williston Park) 2013 Nov;27(11):1166-73 PMID: 24575547 03/01/2014
  • Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? (Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B) Oncologist 2014 Mar;19(3):266-74 PMID: 24569947 PMCID: PMC3958454 02/27/2014
  • Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. (Eifel PJ, Ho A, Khalid N, Erickson B, Owen J) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):249-56 PMID: 24411621 01/15/2014
  • ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. (Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Am J Clin Oncol 2013 Aug;36(4):415-22 PMID: 23872794 07/23/2013
  • Comparison of various online strategies to account for interfractional variations for pancreatic cancer. (Ahunbay EE, Kimura B, Liu F, Erickson BA, Li XA) Int J Radiat Oncol Biol Phys 2013 Aug 01;86(5):914-21 PMID: 23845843 07/13/2013
  • Management of respiration-induced motion with 4-dimensional computed tomography (4DCT) for pancreas irradiation. (Tai A, Liang Z, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2013 Aug 01;86(5):908-13 PMID: 23688811 05/22/2013
  • Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 PMID: 23496023 PMCID: PMC3892317 03/19/2013
  • Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin. (Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B, Evans DB) Surgery 2013 Jul;154(1):123-31 PMID: 23305596 01/12/2013
  • Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. (Rich TA, Winter K, Safran H, Hoffman JP, Erickson B, Anne PR, Myerson RJ, Cline-Burkhardt VJ, Perez K, Willett C) Onco Targets Ther 2012;5:161-70 PMID: 22977306 PMCID: PMC3430391 09/15/2012
  • ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. (Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK) Am J Clin Oncol 2012 Aug;35(4):399-405 PMID: 22810416 07/20/2012
  • Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. (Liu F, Erickson B, Peng C, Li XA) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e423-9 PMID: 22436785 03/23/2012
  • American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. (Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D, American Brachytherapy Society) Brachytherapy 2012 Jan-Feb;11(1):58-67 PMID: 22265439 01/24/2012
  • American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. (Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B, American Brachytherapy Society) Brachytherapy 2012 Jan-Feb;11(1):47-52 PMID: 22265437 PMCID: PMC3489267 01/24/2012
  • American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. (Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, Yashar C, Rownd JJ, Viswanathan AN, American Brachytherapy Society) Brachytherapy 2012 Jan-Feb;11(1):68-75 PMID: 22265440 01/24/2012
  • The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31 PMID: 22193645 PMCID: PMC3246394 12/24/2011
  • ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. (Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR, American College of Radiology (ACR)) Gynecol Oncol 2012 Apr;125(1):256-62 PMID: 22155418 12/14/2011
  • Development of an online adaptive solution to account for inter- and intra-fractional variations. (Li XA, Liu F, Tai A, Ahunbay E, Chen G, Kelly T, Lawton C, Erickson B) Radiother Oncol 2011 Sep;100(3):370-4 PMID: 21924781 09/20/2011
  • Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K) Int J Gynecol Cancer 2011 Oct;21(7):1266-75 PMID: 21892091 09/06/2011
  • Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 PMID: 21775070 PMCID: PMC3208721 07/22/2011
  • Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Haddock MG, Erickson B, Willett CG) J Clin Oncol 2011 May 20;29(15_suppl):3517 PMID: 28020336 05/20/2011
  • Helical tomotherapy for anal cancer: Initial clinical outcomes and organ motion. (Siker ML, Qi XS, Hu B, Wong SJ, Li XA, Erickson B) J Clin Oncol 2011 Feb;29(4_suppl):530 PMID: 27985784 02/01/2011
  • ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. (Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Int J Radiat Oncol Biol Phys 2011 Nov 01;81(3):609-14 PMID: 21215531 01/11/2011
  • American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. (Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):641-9 PMID: 21106308 11/26/2010
  • Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 PMID: 20737218 08/26/2010
  • Addressing overutilization in medical imaging. (Hendee WR, Becker GJ, Borgstede JP, Bosma J, Casarella WJ, Erickson BA, Maynard CD, Thrall JH, Wallner PE) Radiology 2010 Oct;257(1):240-5 PMID: 20736333 08/26/2010
  • Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. (Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium) Int J Radiat Oncol Biol Phys 2011 Feb 01;79(2):348-55 PMID: 20472347 05/18/2010
  • Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. (Viswanathan AN, Erickson BA) Int J Radiat Oncol Biol Phys 2010 Jan 01;76(1):104-9 PMID: 19619956 07/22/2009
  • Extrapolation of normal tissue complication probability for different fractionations in liver irradiation. (Tai A, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2009 May 01;74(1):283-9 PMID: 19289259 03/18/2009
  • Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. (Tai A, Erickson B, Khater KA, Li XA) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):900-7 PMID: 18262101 02/12/2008
  • Image-based brachytherapy: a forum for collaboration between radiation oncologists and diagnostic radiologists. (Erickson B) J Am Coll Radiol 2005 Sep;2(9):753-8 PMID: 17411923 04/07/2007
  • Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K) Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1081-7 PMID: 17398031 04/03/2007
  • Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. (Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson BA, Wang D, Schultz CJ, Firat SY, Wilson JF) Int J Radiat Oncol Biol Phys 2007 Jun 01;68(2):581-91 PMID: 17331669 03/03/2007
  • Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C, GEC ESTRO Working Group) Radiother Oncol 2006 Jan;78(1):67-77 PMID: 16403584 01/13/2006
  • BCL10 expression in ocular adnexal lymphomas. (Vejabhuti C, Harris GJ, Erickson BA, Nishino H, Chevez-Barrios P, Chang CC) Am J Ophthalmol 2005 Nov;140(5):836-843 PMID: 16310461 11/29/2005
  • American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. (Small W Jr, Erickson B, Kwakwa F) Int J Radiat Oncol Biol Phys 2005 Dec 01;63(5):1502-7 PMID: 16109462 08/20/2005
  • Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. (Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J) Int J Radiat Oncol Biol Phys 2005 Nov 15;63(4):1083-92 PMID: 16099599 08/16/2005
  • Maintenance of certification for radiation oncology. (Kun LE, Ang K, Erickson B, Harris J, Hoppe R, Leibel S, Davis L, Hattery R) Int J Radiat Oncol Biol Phys 2005 Jun 01;62(2):303-8 PMID: 15890568 05/14/2005
  • Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). (Pötter R, Dimopoulos J, Kirisits C, Lang S, Haie-Meder C, Briot E, Dumas I, Van Limbergen E, De Brabandere M, Nulens A, Erickson B, Rownd J, Petrow P) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):293-5; author reply 295-6 PMID: 15850940 04/27/2005
  • MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates. (Akansel G, Hendrix L, Erickson BA, Demirci A, Papke A, Arslan A, Ciftci E) Eur J Radiol 2005 Feb;53(2):175-81 PMID: 15664279 01/25/2005
  • Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. (Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1144-53 PMID: 15519786 11/03/2004
  • Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. (Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M, Image-Guided Brachytherapy Working Group) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1160-72 PMID: 15519788 11/03/2004
  • A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer. (Wong SJ, Sadasiwan C, Erickson B, Ota D, Mulkerin D, Thomas J, Holen K, Meadows S, Telford G, Gore E) J Clin Oncol 2004 Jul 15;22(14_suppl):3771 PMID: 28014136 07/15/2004
  • CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. (Mai J, Rownd J, Erickson B) Brachytherapy 2002;1(1):27-35 PMID: 15062184 04/06/2004
  • The sculpted pear: An unfinished brachytherapy tale. (Erickson BA) Brachytherapy 2003;2(4):189-99 PMID: 15062126 04/06/2004
  • Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. (Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ) Am J Clin Oncol 2004 Feb;27(1):51-6 PMID: 14758134 02/06/2004
  • High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. (Firat S, Murray K, Erickson B) Int J Radiat Oncol Biol Phys 2003 Sep 01;57(1):201-7 PMID: 12909234 08/12/2003
  • Improved survival in resected biliary malignancies. (Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, Wilson SD, Demeure MJ, Rilling WS, Dua KS, Pitt HA) Surgery 2002 Oct;132(4):555-63; discission 563-4 PMID: 12407338 10/31/2002
  • Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. (Jones R, Gore E, Mieler W, Murray K, Gillin M, Albano K, Erickson B) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):989-95 PMID: 11958893 04/18/2002
  • The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B, American Brachytherapy Society) Int J Radiat Oncol Biol Phys 2002 Jan 01;52(1):33-48 PMID: 11777620 01/05/2002
  • Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer. (Mai J, Erickson B, Rownd J, Gillin M) Int J Radiat Oncol Biol Phys 2001 Nov 15;51(4):1131-41 PMID: 11704338 11/13/2001
  • Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. (Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2001;51(3 Suppl 2):58-9 PMID: 11641017 10/20/2001
  • In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. (Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA) Am J Clin Oncol 2001 Oct;24(5):522-9 PMID: 11586108 10/05/2001
  • Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry. (Decker WE, Erickson B, Albano K, Gillin M) Int J Radiat Oncol Biol Phys 2001 Jun 01;50(2):561-7 PMID: 11380246 05/31/2001
  • Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. (Firat S, Erickson B) Gynecol Oncol 2001 Feb;80(2):213-20 PMID: 11161862 02/13/2001
  • CT guidance assists brachytherapy for gynecologic disease. (Erickson B) Diagn Imaging (San Franc) 2000 Nov;22(11):167-71, 191 PMID: 11148961 01/10/2001
  • MRI and ultrasound guide gynecologic brachytherapy. (Erickson B) Diagn Imaging (San Franc) 2000 Dec;22(12):78-83 PMID: 11146805 01/09/2001
  • The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. (Nag S, Erickson B, Parikh S, Gupta N, Varia M, Glasgow G) Int J Radiat Oncol Biol Phys 2000 Oct 01;48(3):779-90 PMID: 11020575 10/06/2000
  • p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. (Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ) Surgery 2000 Oct;128(4):520-30 PMID: 11015084 10/03/2000
  • The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D) Int J Radiat Oncol Biol Phys 2000 Aug 01;48(1):201-11 PMID: 10924990 08/05/2000
  • The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. (Nag S, Orton C, Young D, Erickson B) Gynecol Oncol 1999 Apr;73(1):111-8 PMID: 10094890 03/30/1999
  • Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation. (Demeure MJ, Doffek KM, Komorowski RA, Redlich PN, Zhu YR, Erickson BA, Ritch PS, Pitt HA, Wilson SD) Surgery 1998 Oct;124(4):663-9 PMID: 9780986 10/22/1998
  • Biliary tree malignancies. (Erickson BA, Nag S) J Surg Oncol 1998 Mar;67(3):203-10 PMID: 9530894 04/08/1998
  • Interstitial implantation of gynecologic malignancies. (Erickson B, Gillin MT) J Surg Oncol 1997 Dec;66(4):285-95 PMID: 9425337 01/13/1998
  • Clinical indications for brachytherapy. (Erickson B, Wilson JF) J Surg Oncol 1997 Jul;65(3):218-27 PMID: 9236932 07/01/1997
  • CT-guided interstitial implantation of gynecologic malignancies. (Erickson B, Albano K, Gillin M) Int J Radiat Oncol Biol Phys 1996 Oct 01;36(3):699-709 PMID: 8948356 10/01/1996
  • Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy. (Erickson BA, Harris GJ, Lewandowski MF, Murray KJ, Massaro BM) Int J Radiat Oncol Biol Phys 1995 Feb 01;31(3):651-60 PMID: 7852132 02/01/1995
  • Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylinders. (Gore E, Gillin MT, Albano K, Erickson B) Int J Radiat Oncol Biol Phys 1995 Jan 01;31(1):165-70 PMID: 7995748 01/01/1995
  • Lacrimal collecting system lymphomas: integration of magnetic resonance imaging and therapeutic irradiation. (Erickson BA, Massaro BM, Mark LP, Harris GJ) Int J Radiat Oncol Biol Phys 1994 Jul 30;29(5):1095-103 PMID: 8083079 07/30/1994
  • Altered motility causes the early gastrointestinal toxicity of irradiation. (Erickson BA, Otterson MF, Moulder JE, Sarna SK) Int J Radiat Oncol Biol Phys 1994 Mar 01;28(4):905-12 PMID: 8138444 03/01/1994
  • Nasopharyngeal brachytherapy. (Erickson BA, Wilson JF) Am J Clin Oncol 1993 Oct;16(5):424-43 PMID: 8213626 10/01/1993
  • Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment. (Erickson BA, Harris GJ, Enke CA, Murray KJ, Massaro BM, Hanson GA, Hansen RM, Anderson T, Wilson JF) Radiology 1992 Oct;185(1):63-70 PMID: 1523336 10/01/1992
  • Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. (Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA) J Neurooncol 1991 Dec;11(3):235-9 PMID: 1726656 12/01/1991
  • Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients. (Hansen R, Erickson B, Komaki R, Janjan N, Cox J, Wilson JF, Anderson T) Breast Cancer Res Treat 1991 Jan-Feb;17(3):171-7 PMID: 2039839 01/01/1991
    • Last update: 09/22/2017
    jenkins-FCD Prod-130 96200611f8481f0aa4f84230b11dd74d063847a3